{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:18:41Z","timestamp":1791566321085,"version":"4.3.4"},"reference-count":31,"publisher":"BMJ","issue":"11","funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-111-105"],"award-info":[{"award-number":["DMR-111-105"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-112-087"],"award-info":[{"award-number":["DMR-112-087"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V110C-175"],"award-info":[{"award-number":["V110C-175"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V111C-188"],"award-info":[{"award-number":["V111C-188"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V112C-164"],"award-info":[{"award-number":["V112C-164"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Council R.O.C.","award":["MOST 110-2314-B-075-027-MY3"],"award-info":[{"award-number":["MOST 110-2314-B-075-027-MY3"]}]},{"name":"Taiwan Ministry of Health and Welfare Clinical Trial Center","award":["MOHW112-TDU-B-212-144004"],"award-info":[{"award-number":["MOHW112-TDU-B-212-144004"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2024,9,13]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Clinical studies have shown that glucagon-like peptide-1 receptor agonists (GLP-1 RA) can have beneficial effects on cardiopulmonary function. We conducted this longitudinal cohort study to compare the risk of cardiopulmonary outcomes and mortality between GLP-1 RA use and no use in patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disease (COPD).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The study identified 8060 matched GLP-1 RA users and non-users from Taiwan\u2019s National Health Insurance Research Database from 1 January 2008 to 31 December 2019. Cox proportional hazards models were used to determine the risk of cardiopulmonary outcomes between GLP-1 RA users and non-users.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The mean follow-up time was 2.51 and 2.46 years for GLP-1 RA users and non-users, respectively. In the matched cohorts, GLP-1 RA users had a significantly lower risk of mortality (adjusted HR (aHR) 0.46, 95% CI 0.38 to 0.56), cardiovascular events (aHR 0.73, 95% CI 0.65 to 0.82), non-invasive positive pressure ventilation (aHR 0.66, 95% CI 0.47 to 0.93), invasive mechanical ventilation (aHR 0.64, 95% CI 0.51 to 0.8) and bacterial pneumonia (aHR 0.76, 95% CI 0.65 to 0.88) than GLP-1 RA non-users. The subsequent analyses for various subgroup and medication duration also showed that GLP-1 RA was associated with a significantly lower risk of mortality, cardiovascular events, ventilation support and bacterial pneumonia than non-GLP-1 RA.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This nationwide cohort study showed that GLP-1 RA had a lower risk of cardiopulmonary outcomes and all-cause mortality than non-GLP-1 RA in patients with T2D and COPD. GLP-1 RA may help manage diabetes in people with COPD.<\/jats:p>\n<\/jats:sec>","DOI":"10.1136\/thorax-2023-221040","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T17:20:38Z","timestamp":1727803238000},"page":"1017-1023","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD"],"prefix":"10.1136","volume":"79","author":[{"given":"Fu-Shun","family":"Yen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuu-Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-Shun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8209-9627","authenticated-orcid":false,"given":"Chii-Min","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"2024101604001469000_79.11.1017.1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)00470-6"},{"key":"2024101604001469000_79.11.1017.2","unstructured":"GBD . Institute for health metrics and evaluation, global health data exchange, global burden of disease study 2019 (GBD 2019) data resources, GBD results tool, terms and conditions. 2019. Available: https:\/\/vizhub.healthdata.org\/gbd-results [Accessed 13 Mar 2023]."},{"key":"2024101604001469000_79.11.1017.3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000369863","article-title":"Chronic obstructive pulmonary disease and diabetes mellitus: a systematic review of the literature","volume":"89","author":"Gl\u00e4ser","year":"2015","journal-title":"Respiration"},{"key":"2024101604001469000_79.11.1017.4","first-page":"1030","article-title":"Mechanisms Linking COPD to Type 1 and 2 Diabetes Mellitus: Is There a Relationship between Diabetes and COPD?","volume":"58","author":"Park","year":"2022","journal-title":"Med Bogota Colomb"},{"key":"2024101604001469000_79.11.1017.5","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0057-2018"},{"key":"2024101604001469000_79.11.1017.6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications","volume":"398","author":"Brown","year":"2021","journal-title":"Lancet"},{"key":"2024101604001469000_79.11.1017.7","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1666"},{"key":"2024101604001469000_79.11.1017.8","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2015-0311OC"},{"key":"2024101604001469000_79.11.1017.9","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1577"},{"key":"2024101604001469000_79.11.1017.10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74912-1","article-title":"GLP-1 receptor agonist ameliorates experimental lung fibrosis","volume":"10","author":"Fandi\u00f1o","year":"2020","journal-title":"Sci Rep"},{"key":"2024101604001469000_79.11.1017.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.06.015"},{"key":"2024101604001469000_79.11.1017.12","doi-asserted-by":"publisher","DOI":"10.2337\/db21-0688"},{"key":"2024101604001469000_79.11.1017.13","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S350133"},{"key":"2024101604001469000_79.11.1017.14","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1794"},{"key":"2024101604001469000_79.11.1017.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071380","article-title":"Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study","volume":"379","author":"Pradhan","year":"2022","journal-title":"BMJ"},{"key":"2024101604001469000_79.11.1017.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204859","article-title":"Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject design","volume":"13","author":"Yen","year":"2018","journal-title":"PLoS One"},{"key":"2024101604001469000_79.11.1017.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.04.069"},{"key":"2024101604001469000_79.11.1017.18","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.2147\/COPD.S174265","article-title":"Validity of ICD9-CM codes to diagnose chronic obstructive pulmonary disease from National Health Insurance claim data in Taiwan","volume":"13","author":"Ho","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024101604001469000_79.11.1017.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61382-8"},{"key":"2024101604001469000_79.11.1017.20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s11606-007-0310-5","article-title":"Chronic illness with complexity: implications for performance measurement of optimal glycemic control","volume":"22 Suppl 3","author":"Meduru","year":"2007","journal-title":"J Gen Intern Med"},{"key":"2024101604001469000_79.11.1017.21","first-page":"15","article-title":"Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization","volume":"14","author":"Young","year":"2008","journal-title":"Am J Manag Care"},{"key":"2024101604001469000_79.11.1017.22","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B"},{"key":"2024101604001469000_79.11.1017.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01273-9"},{"key":"2024101604001469000_79.11.1017.24","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10020235","article-title":"The Impact of Diabetes Mellitus in Patients with Chronic Obstructive Pulmonary Disease (COPD) Hospitalization","volume":"10","author":"Gunasekaran","year":"2021","journal-title":"J Clin Med"},{"key":"2024101604001469000_79.11.1017.25","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0138"},{"key":"2024101604001469000_79.11.1017.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61295-6"},{"key":"2024101604001469000_79.11.1017.27","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-015-0465-x","article-title":"Gliptin and GLP-1 analog treatment improves survival and vascular inflammation\/dysfunction in animals with lipopolysaccharide-induced endotoxemia","volume":"110","author":"Steven","year":"2015","journal-title":"Basic Res Cardiol"},{"key":"2024101604001469000_79.11.1017.28","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/S2213-2600(20)30329-5","article-title":"Respiratory research funding is inadequate, inequitable, and a missed opportunity","volume":"8","author":"Williams","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024101604001469000_79.11.1017.29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024101604001469000_79.11.1017.30","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-024-02154-w","article-title":"The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis","volume":"23","author":"Ali","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"2024101604001469000_79.11.1017.31","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab818"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2023-221040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T18:24:03Z","timestamp":1729103043000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2023-221040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,10,16]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/thorax-2023-221040"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2023-221040","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}